AUCKLAND, NEW ZEALAND: Cancer diagnostics company Pacific Edge announced the appointment of Dr Peter Meintjes, an experienced molecular diagnostics and genomics business leader, as its new Chief Executive Officer. Dr Meintjes, a New Zealand citizen currently resident in Boston, brings to Pacific Edge extensive global diagnostics, biotechnology, and commercial leadership expertise. He also has a…
Tag: Pacific Edge
Cancer diagnostics business, Pacific Edge to dual list on ASX
AUCKLAND, NEW ZEALAND: Cancer diagnostics business, Pacific Edge Limited (PEB) will lodge an application with the Australian Stock Exchange (ASX) to dual list as a Foreign Exempt Entity. Subject to the ASX accepting the application, PEB expects to be dual-listed on the ASX by the end of September 2021. Pacific Edge intends to maintain its…